SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 61 filers reported holding SUTRO BIOPHARMA INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,863 | -96.8% | 825 | -95.7% | 0.00% | – |
| Q2 2023 | $88,252 | -88.9% | 18,979 | -89.0% | 0.00% | -100.0% |
| Q1 2023 | $795,245 | +125.3% | 172,131 | +293.9% | 0.00% | – |
| Q4 2022 | $353,048 | +4943.5% | 43,694 | +3271.5% | 0.00% | – |
| Q3 2022 | $7,000 | -66.7% | 1,296 | -67.1% | 0.00% | – |
| Q2 2022 | $21,000 | -91.1% | 3,939 | -86.3% | 0.00% | – |
| Q1 2022 | $236,000 | -78.2% | 28,671 | -60.7% | 0.00% | -100.0% |
| Q4 2021 | $1,085,000 | +35.1% | 72,942 | +71.6% | 0.00% | – |
| Q3 2021 | $803,000 | -68.6% | 42,505 | -69.1% | 0.00% | -100.0% |
| Q2 2021 | $2,558,000 | -33.7% | 137,601 | -18.9% | 0.00% | 0.0% |
| Q1 2021 | $3,860,000 | +255.8% | 169,594 | +239.4% | 0.00% | +100.0% |
| Q4 2020 | $1,085,000 | +8246.2% | 49,971 | +3913.7% | 0.00% | – |
| Q3 2020 | $13,000 | -23.5% | 1,245 | -44.0% | 0.00% | – |
| Q2 2020 | $17,000 | -45.2% | 2,225 | -27.5% | 0.00% | – |
| Q1 2020 | $31,000 | +29.2% | 3,069 | +40.7% | 0.00% | – |
| Q4 2019 | $24,000 | +166.7% | 2,182 | +119.7% | 0.00% | – |
| Q3 2019 | $9,000 | -71.9% | 993 | -64.9% | 0.00% | – |
| Q2 2019 | $32,000 | +68.4% | 2,830 | +66.2% | 0.00% | – |
| Q1 2019 | $19,000 | +18.8% | 1,703 | +1.1% | 0.00% | – |
| Q4 2018 | $16,000 | – | 1,685 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
| Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
| Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
| Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
| FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
| BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
| Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
| Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |